LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 91 filers reported holding LEGEND BIOTECH CORP in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,343 | -3.0% | 19,989 | -0.3% | 0.06% | -24.7% |
| Q2 2023 | $1,384 | +20.7% | 20,054 | -11.6% | 0.07% | +40.4% |
| Q1 2023 | $1,147 | +2.4% | 22,691 | +1.2% | 0.05% | +13.0% |
| Q4 2022 | $1,120 | -99.9% | 22,429 | -1.6% | 0.05% | -4.2% |
| Q3 2022 | $930,000 | -21.5% | 22,804 | +5.9% | 0.05% | +14.3% |
| Q2 2022 | $1,185,000 | +46.7% | 21,540 | -3.1% | 0.04% | +27.3% |
| Q1 2022 | $808,000 | -15.0% | 22,228 | +8.9% | 0.03% | +37.5% |
| Q4 2021 | $951,000 | +6692.9% | 20,409 | +7215.1% | 0.02% | – |
| Q3 2021 | $14,000 | +27.3% | 279 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | 0.0% | 279 | -27.0% | 0.00% | – |
| Q1 2021 | $11,000 | 0.0% | 382 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | – | 382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |